Romeo2 PAD is an innovative fixation method that allows posterior fusion while reducing operative time and muscle trauma.
Benefits:
- Central peek cage :The central PEEK cage includes a graft window and is designed to promote the fusion process.
- Rigid interspinous fixation:This innovative fixation method allows posterior fusion while reducing operative time and muscle trauma
- Polyaxial plate:The plate has 30° of polyaxiality (15° in each direction) and is designed to adapt well to the different varieties of the patient anatomy.
- One step locking mechanism:The easy one step locking mechanism allows the surgeon to squeeze, fix and lock the implant at the same time.
- 360° fusion with JULIET® cages:The combination of the ROMEO®2 PAD and the JULIET® cages through a small incision and a unilateral approach completes the 360° fusion.
- Compact set:Only one box of intuitive instruments.
About Interspinous Devices
Interspinous spacers sometimes also called as Interspinous process decompression systems, are the devices implanted between vertebral spinous processes. These spacers are made up of a very strong but lightweight metal (titanium) which is biocompatible in the human body. These devices are imbedded in body to confine painful motion else enabling normal motion and to treat lumbar spinal stenosis, discogenic low-back pain, facet syndrome, disc herniations, and non-traumatic instability. Lumbar spinal stenosis is a thinning of the spinal canal in the lower back which causes compression on nerves and it is developed gradually with age. Radiology tests are used to confirm a diagnosis of moderate degenerative lumbar spinal stenosis. People with lumbar spinal stenosis experience pain but may also have weakness in their leg, lower back and buttocks, numbness, tingling.
The Interspinous spacer are implanted between those vertebrae in such a way that it prevents the patient from bending too far backward which causes pain by surgical procedure. The procedure is very small and sometimes patient can go home within a day.The increasing prevalence of spinal stenosis due to aging, arthritis, heredity and increased demand of surgical procedures that improved lifestyle and comfort will drive the Interspinous spacer market. The adoption of spacers are increasing due to low complication rate as compared to decompression and spinal fusion. The Interspinous spacers are widely used in geriatric population as per Medicare data due to old age patient are not comfortable with surgery due to their health conditions. Source:Transparency Market Research (TMR)
About Spineart
Spineart is a privately held medical device company focused on simplifying the surgical act by designing, developing and promoting safe and efficient solutions to spine surgeons, operating room teams, and patients. The company was established in 2005 and is currently operating in 46 countries worldwide.Spineart is a pioneer in its field, having introduced unique patented and clinically validated technologies in the fields of Minimally Invasive Surgery, Motion Preservation, Fusion, Biologics, and Fractures Treatment.Spineart markets a complete portfolio combining traceable barcoded sterile packed implants with compact instrument sets, thus proudly promoting greater safety, cost-efficiency, and compliance at the hospital. Please visit:http://www.spineart.com